Proto-oncogenes are involved in controlling major cel lular functions such as proliferation and differentiation (Bishop 1985) . One of the most extensively studied proto-oncogenes is c-fos, a cellular homolog of FBJ virus (Curran et al. 1982) . c-/os encodes a conserved nu clear phosphoprotein of 55 kD that is capable of binding to DNA Sambucetti and Curran 1986) . Expression of the c-/os gene occurs during fetal (Adamson et al. 1985; Muller et al. 1985b ) and neo natal development (Kasik et al. 1987 ) and in adult tissues , suggesting a role in develop ment and in normal cellular physiology. In tissue cul ture cells c-/os is induced rapidly and transiently by a large variety of external stimuli, many of which are me diated by ligand binding (Greenberg and Ziff 1984; Kruijer et al. 1985; Curran and Morgan 1985; Morgan and Curran 1986; Wan et al. 1987) . These findings suggest that c-/os is involved in gene regulation events that are associated with signal ^Corresponding author.
transduction. c-/os gene expression is also implicated in cell differentiation, because it often occurs concomi tantly with differentiation events (Gonda and Metcalf 1984; Mitchell et al. 1985; Muller et al. 1985a; Curran and Morgan 1985; Kruijer et al. 1985) . Introduction of the c-/os gene into undifferentiated F9 embryonal carci noma (EC) cells leads to the types of morphological dif ferentiation of these cells that accompanies expression of genes characteristic of later-stage embryos (Muller and Wagner 1984; Ruther et al. 1985) .
Despite its broad expression and far-reaching func tional implications, the exact role of the c-/os gene has remained elusive. To assess the functions of this gene, we prepared a plasmid that allows expression of RNA complementary to endogenous c-/os mRNA and studied the effects of its expression in F9 EC cells. As shown first by Izant and Weintraub (1984, 1985) and then by Kim and Wold (1985) , thymidine kinase gene expression is inhibited following introduction of antisense con structs into a variety of cells. Inhibition of mRNA matu ration, transport, or translation by antisense sequences Blockade of c-fos expression by antisense RNA has been observed for hspZO (McGarry and Lindquist 1986) , globin (Melton 1985) , c-myc (Heikkila et al. 1987) , and for myosin heavy chain (Knecht and Loomis 1987) , providing nonproducer phenotypes for these genes. Re cently, two groups reported that introduction of c-/os antisense DNA into N1H-3T3 cells has inhibitory effects on cell growth and DNA repHcation (Holt et al. 1986; Nishikura and Murray 1987) .
We show here that introduction of a c-/os antisense construct into F9 EC cells does not exert adverse effects on cell growth, yet results in virtually complete inhibi tion of c-/os gene expression induced by interferon and phorbol ester. Further, we describe an unexpected finding that c-/os antisense RNA expression is asso ciated with a reduction in c-myc mRNA expression which is otherwise very high in undifferentiated F9 EC cells. Possible mechanisms of the reduced expression of the two genes are discussed in the context of the effect of cycloheximide.
Results

Construction of a plasmid that permits constitutive expression of c-fos antisense RNA and its introduction into F9 EC cells
We have chosen a vector that allows constitutive ex pression of c-fos antisense RNA, rather than a vector that induces the antisense RNA (Holt et al. 1986 ; Nishi kura and Murray 1987) upon stimulation, because we assumed that the constant presence of c-/os antisense RNA is more efficient in blocking expression of c-/os gene. As shown schematically in Figure 1 , a 410-bp 5' fragment of the mouse genomic c-/os gene was placed in reverse orientation with respect to the direction of tran scription under the control of the RSV promoter of the mammalian expression vector pRSV-2 (Materials and methods). The resultant plasmid was termed pAFOS-2. The c-/os fragment used contained most of the first exon and a 5'-flanking region including the TATA box and cap site. The RSV promoter was used because its activity is strong even in undifferentiated F9 EC cells in which viral promoters often function weakly. Included in this vector is the termination signal and polyadenylation site derived from SV40 (Fig. 1) . The same c-fos fragment placed in the sense orientation was also prepared and used as a control (pSFOS-2). Plasmids pAFOS-2 and pSFOS-2 were stably introduced into undifferentiated F9 EC cells with pSV2-neo as a selectable marker. Forma tion of visible colonies was evident within 10 days after selection, and transfection efficiencies were essentially the same for these two plasmids and for pSV2-neo (5 X 10"^ to 8 X 10-^). All G418-resistant cells showed rapid cell growth, comparable to untransfected cells, and exhibited a morphology characteristic of undifferen tiated F9 EC cells (see below). About 35 independent clones were isolated after transfection with either pAFOS-2 or pSFOS-2, and their RNAs were screened for expression of c-/os antisense or sense RNA by dot hy bridization using ^^P-labeled strand-specific DNA probes (Materials and methods). As seen in Table 1 , about 20% of transfected cells contained detectable levels of c-fos antisense or sense RNA. Control untransfected cells or cells transfected with pSV2-neo alone did not contain either sense or antisense RNA (data not shown). As shown below (Fig. 5) , Northern blot hybridization con firmed that antisense RNA expressed in these cells is of the expected size. Table 1 also presents clonal frequency for blockade of c-fos mRNA expression tested following interferon (IFN) treatment for 30 min. Four of six antisense clones had lower levels of c-/os message (reduced by more than 75%) compared to control F9 cells. In con trast, none of six transfectants obtained either with the sense plasmid or pSV-neo showed detectable blockade in c-fos mRNA expression (Table 1) . It is most likely that the blockage of the endogenous c-/os mRNA is mediated by antisense RNA expression, and not due to clonal vari ability (see below). Two antisense clones expressing rela tively high levels of c-fos antisense RNA failed to block c-fos mRNA induced by IFN, for reasons not clear at present. It is possible that the site of plasmid integration or variability in RNA unwindase activity (Rebagliati and Melton 1987; Wagner and Nishikura 1988) influences efficient blocking of gene expression. Two antisense clones, 3A9 and 2A36, which express high levels of c-fos antisense RNA and block the endogenous c-/os gene ex pression, were chosen for further analysis.
To examine the copy number of c-/os antisense plasmids integrated into these clones, Southern blot hy bridization was performed (Fig. 2) . Cellular DNA was di gested with BamHl and Hindlll and hybridized with ^^P-labeled probe prepared from the Hindi fragment of the c-fos gene, which should detect the endogenous as well as the exogenously introduced c-/os sequences. Diges tion with BamHl and Hindlll should generate an ~5-kb band of the endogenous c-/os gene, and an ~1.3-kb band Figure 1 . Construction of plasmid pAFOS-2 that allows constitutive expression of c-/os antisense RNA. A 410-bp HirzcII fragment of the mouse c-/os gene that contains the promoter region and most of the first exon was subcloned into M13 mpl9 in both orientations. The Hindlll-Xbal frag ments of the subclones were cloned into the mammalian expression vector pRSV-2. pAFOS-2 cloned in the reverse orientation generates c-/os antisense RNA, and pSFOS-2 cloned in the native orie^ntation produces c-/os sense RNA. of the integrated pAFOS-2 and pSFOS-2. As seen in Figure 2 , untransfected F9 EC cells had only a ~5-kb band, as expected. DNA from clones 3A9 and 2A36 transfected with the antisense plasmid, as well as clone 3S1 transfected with the sense counterpart had the ex pected 1.3-kb band, in addition to a weak band of ~5 kb. The intensity of the 1.3-kb band was at least 100-fold higher than that of the 5-kb band, indicating that these transformed cells contained multiple copies of c-/os sense or antisense plasmids without major rearrange ment of the endogenous c-/os gene or of the plasmids.
Blockade of c-fos niRNA induction in F9 EC cells expressing c-fos antisense RNA
Previously we reported that both IFN7 and IFN-a/p in duce c-/os mRNA in a number of cells including F9 EC cells (Wan et al. 1988) . The c-/os induction by IFN is rapid and transient, similar to its induction by many other agents (Greenberg and Ziff 1984; Kruijer et al. 1985) . IFN also induces expression of major histocompatibility (MHC) class 1 genes in F9 EC cells ; the poly morphic MHC class 1 genes are expressed in the majority of tissue culture cells, but not in undifferentiated F9 EC cells (Gmur et al. 1980; Rosenthal et al. 1984) . In addi tion, we found that the protein kinase C activator, phorbol ester (TPA) induces c-/os gene expression in F9 EC cells (see below), as it does in other tissue culture cells (Greenberg and Ziff 1984; Bravo et al. 1985; Mitchell et al. 1986 ). Neither IFN nor TPA induces morphological differentiation of F9 EC cells. Expression of the endogenous c-/os mRNA in 0/3 0/3 * F9 EC cells were cotransfected with pAFOS-2 or pSFOS-2 (10 |xg) and pSV2-neo (1 |jLg). The transfection efficiencies by pAFOS-2 and pSFOS-2 were equivalent to that seen by pSV2-neo alone (5-8 x 10 "^j. ^ Three independent pools of cells (containing -50 colonies) se lected by pSV-neo alone were tested. ^ Total RNA from these clones was screened for expression of c-/os sense or antisense RNA by dot hybridization using strandspecific probes. ** Cells were tested for their ability to block endogenous c-/os mRNA expression (reduced by more than 75%) induced by treatment with IFN for 0.5 and 4 hr. clones expressing c-/os antisense RNA was examined in Northern blot hybridization using a highly sensitive, single-strand DNA probe (Materials and methods) corre sponding to the fourth exon of the c-/os gene. With this probe no hybridization with RNA transcribed from the introduced plasmids is expected, since they do not have the fourth exon c-fos sequence. Results are shown in Figure 3 , A and B. Untreated control cells (F9 neo^ transfected with pSV2-neo alone or clone 3S1, trans fected with the sense plasmid) contained a very low basal level of a c-/o5 mRNA. Untreated 3A9 and 2A36 clones did not have detectable basal c-/os mRNA. A high level of 2.2-kb c-/os mRNA was induced in the two con trol cell lines 30 min after treatment with IFN at 1000 U/ml, which returned to a baseline after 4 hr. In con trast, c-/os mRNA was almost undetectable in clones 3A9 and 2A36 up to 4 hr after IFN treatment. Densitom etry analysis indicated that the levels of c-/os mRNA in 3A9 and 2A36 clones were 35-fold and 20-fold, respec tively, lower than in control F9 transfected with the neo gene alone, indicating the failure of c-fos mRNA induc tion in these clones. However, these antisense clones and control F9 cells induced 1.9-kb MHC class I mRNA at an equivalent level 4 hr after IFN treatment (Fig. 3A) . Thus, the reduced c-/os mRNA expression seen in the antisense clones is not due to the loss of the ability to respond to IFN, These results suggest that c-fos anti- , and a clone ex pressing the sense RNA (3S1) were treated with IFN-a/p at 1000 U/ml for the indicated time in tervals. The mRNA for c-fos, c-myc, and MHC class I genes was detected by Northern blot hy bridization with 20 |xg of total RNA using ^^P-labeled single-stranded probes for the fourth exon of the c-/os, the first exon of c-myc, and for the fourth exon of a MHC class I gene (H-2L'*), re spectively (Kaufmann et al. 1987) . {B) F9 clones were preincubated with the medium with 0.5% FBS for 18 hr and treated with TPA at 50 ng/ml for the indicated time intervals. Twenty micro grams of total RNA was hybridized with ^^p-labeled probes for the fourth exon of c-fos, the first exon of c-myc, the entire hspJO gene, and the P53 gene. Arrows indicate the position of 18S RNA.
sense RNA blocked the expression of the endogenous c-fos gene and that c-/os gene expression is not obliga tory for the expression of MHC class I genes induced by IFN.
The blockade of the expression of the endogenous C-/OS gene was also observed in clones 3A9 and 2A36 after TPA treatment. As seen in Figure 3B , a large amount of c-/os mRNA accumulated in control F9 cells (both untransfected and clone 3S1) 30 min after treat ment with 50 ng/ml of TPA. As in the case of IFN treat ment, the levels of c-/os mRNA decreased sharply after wards, and returned to baseline after 4 hr. In clone 3A9, however, the c-/os mRNA level after TPA treatment was 50-fold less than control F9. Similarly, in clone 2A36 the amount of c-/os mRNA induced by TPA was 14-fold less than the control. These findings indicate that the induction of the en dogenous c-/os gene mRNA by the two external stimuli is severely affected in cells expressing c-/os antisense RNA. The amount of c-/os mRNA induced in control cells by TPA was at least 10 times greater than that seen after IFN treatment, as judged by the intensity of the bands and the exposure time required for their visualiza tion. The basis of the quantitative difference in c-/os mRNA induction seen by the two agents is not clear.
Failure of c-fos protein production in P9 clones expressing c-fos antisense RNA
To confirm that blockade of c-/os mRNA expression seen in cells expressing c-/os antisense RNA results in the failure of c-/os protein production, these clones were Stained immunofluorescently after TPA treatment. Af finity-purified rabbit antibody raised against the M pep tide of mouse c-/os protein was em ployed; it has been shown to react specifically with the c-/os protein localized in nuclei in a number of cells. F9 cells were treated with TPA for 2 hr and the presence of the c-fos protein was examined after incubation with the antibody followed by reaction with biotinylated antirabbit antibody and fluorescent avidin. Figure 4 shows specific staining of control F9 cells and the 3A9 antisense clone. Untreated F9 cells were negative for c-fos protein regardless of the presence of c-/os antisense RNA (Fig. 4A,C,a,c,) . After treatment with TPA, control F9 cells exhibited strong fluorescent staining concentrated in nuclei (Fig. 4B) . The maximum staining was observed 2 hr after the initiation of TPA treatment; staining was much weaker at 1 and 4 hr. Because of the small cyto plasmic area of F9 cells, nuclear localization of the c-/os protein was not as clearly demonstrable as in NIH-3T3 cells observed after stimulation with FES (data not shown). As shown in Figure 4 , significant immunofluorescent staining was not observed in clone 3A9 after TPA treatment (Fig. 4D) , demonstrating the failure of the production of the c-/os protein in the antisense clone. No nuclear staining was detected by a control rabbit antibody with unrelated specificity (data not shown).
Reduced c-myc mRNA expression in F9 clones expressing c-fos antisense RNA
The expression of c-/os and c-myc genes occurs in a se quential fashion in certain cells when stimulated with growth factors (Greenberg and Ziff 1984; Bravo et al. 1985) , suggesting a possible linkage in the regulation of the two genes. Thus, it was of interest to examine the levels of c-myc mRNA in the clones that failed to express c-/os gene. F9 EC cells express high levels of c-myc mRNA in an undifferentiated state, which diminishes following retinoic acid-induced differ entiation (Dony et al. 1985) . In addition, undifferentiated F9 EC cells express the heat shock hsp70 gene (Morange et al. 1984) as well as the p53 gene (Reich et al. 1983) constitutively. These two genes encode nuclear pro teins, and their expression occurs in association with cell division (Wu et al. 1985; Kaczmarek et al. 1986 ). Similar to c-myc, their mRNA levels decline after reti noic acid-induced differentiation in F9 cells (Dony et al. 1985) .
We studied c-myc gene expression in clones 3A9 and 2A36. As shown in Figure 3 , A and B, control F9 EC cells (both untransfected F9 and clone 3S1) expressed high levels of ~2.4-kb c-myc mRNA as detected by a probe corresponding to the first exon of the mouse c-myc gene. In contrast, the amounts of c-myc mRNA in antisense clones were much lower (Fig. 3A,B) . c-myc levels in 3A9 and 2A36 varied, and were lower by 10-to 50-fold and by 5-to 20-fold than those of control F9 cells, respectively (Fig. 5) . Treatment of these and control cells with either IFN or TPA did not change the levels of c-myc mRNA (Fig. 3A,B) : Although IFN treatment is reported to downregulate c-myc gene expression in certain cells (Dani et al. 1985; Knight et al. 1985) , it did not affect the levels of c-myc mRNA in F9 EC cells (Fig. 3A , see also Wan et al. 1988 ). The mRNA levels for the hsp70 and p53 genes in clones 3A9 and 2A36 were comparable to those of control cells, regardless of TPA treatment (Fig.  3B) , indicating that the observed reduction in c-myc mRNA expression is due to selective down regulation of c-myc gene expression in cells expressing c-/os antisense RNA.
Induction of c-fos and c-myc mRNA by cycloheximide (CHX) treatment
Previously, we and others noted that treatment of F9 EC and other cells with the protein synthesis inhibitor CHX leads to rapid and prolonged expression of c-/os mRNA (Greenberg et al. 1986; Wan et al. 1988 ). In addition, CliX treatment is known to superinduce expression of a number of genes when combined with other stimuli (Greenberg and Ziff 1984; Friedman et al. 1984 ). Superinduction of genes by CHX treatment has been attrib uted to the removal of a labile repressor and or stabiliza tion of mRNA or both (Ringold et al. 1984; Greenberg et al. 1986; Rahmsdorf et al. 1987 ). We examined, by Northern blot hybridization, the expression of c-fos and c-myc mRNA in antisense clone 3A9 and in control clones after CHX treatment (Fig. 5) . Treatment of clone 3A9 with CHX for 5 hr resulted in induction of a large amount of c-/os mRNA. As expected, control clones (un transfected F9 and 3S1) also induced c-/os mRNA at a level comparable to that seen in the antisense clone. These results indicate that the endogenous c-/os gene in clone 3A9 is intact, capable of producing its mRNA, and that c-/os mRNA induced by CHX cannot be blocked by the c-/os antisense RNA. Figure 5 also shows that CHX treatment increases expression of c-/os antisense RNA in clone 3A9. A high level of ~l-kb c-fos antisense tran script was seen in this clone before CHX treatment, as detected by a strand-specific probe corresponding to the Hindi fragment of the c-fos gene (Materials and methods), and CFIX treatment increased the level of the antisense RNA by about 10-fold. Clone 2A36 also ex pressed c-/os antisense RNA of the same size (data not shown). No other bands that proved hybridizable with the antisense probe were found (Fig. 5) . Thus, the in ability of 3A9 clone to suppress c-/os mRNA induction after CHX treatment is not due to the interference with the production of c-/os antisense RNA by CHX. No c-/o5 antisense transcript was found in control F9 cells and in the 3S1 clone regardless of CHX treatment (Fig. 5) . Fur ther, we found that CHX treatment of clone 3A9 leads to reexpression of c-myc mRNA. The steady-state level of c-myc mRNA was about three to four times lower in 3A9 than control F9 cells before CHX treatment in this experiment (Fig. 5) , as tested by a probe detecting the second exon of c-myc (Materials and methods). The level of C-1327C, however, rose by at least 10-fold after 5 hr of CHX treatment. The results indicate that the striking C,D,c,d] were stimulated with TPA (50 ng/ml) for 2 hr. Nuclear localization of the c-/os protein was detected by binding of rabbit antibody specific for the M peptide of the mouse c-/os product . reduction of c-myc expression found in the c-fos antisense clone is not due to the disruption of the c-myc gene, but due to downregulation of production or accu mulation of c-myc mRNA or both. It is not clear whether the reexpression of c-myc mRNA by CHX treatment was dependent on the reexpression of c-/os mRNA.
Morphological differentiation of the F9 clones induced by retinoic acid treatment
F9 EC cells undergo differentiation and become visceral endodermal cells after retinoic acid (RA) treatment (Strickland and Mahdavi 1978) . Treatment of the cells with RA in combination with cAMP directs the cells to differentiate into parietal endodermal cells (Strickland et al. 1980) . These processes accompany the reduction of the stage-specific embryonic antigen (SSEA-1) and new expression of a number of genes, including MHC class I genes (Rosenthal et al. 1984; Wan et al. 1987) . It has been proposed that expression of the c-/os gene is in volved in differentiation of F9 EC cells (Muller and Wagner 1984) and in other cells (Gonda and Metcalf 1984; Mitchel et al. 1985) . To test the ability of clones 3A9 and 2A36 clones to differentiate following RA treat ment, we treated these clones with varying concentra tions of RA starting from 5 x 10"'' M to 10"^ M for up to 7 days with or without cAMP. Control F9 EC cells began to exhibit clear morphological differentiation 3-4 days after addition of RA at concentrations above 10"^ M. Cells became elongated and had enlarged cytoplasmic areas, with obvious retardation of cell division (Strick land and Mahdavi 1978) . Exactly the same changes were noted in 3A9 and 2A36 clones after RA treatment re- gardless of the addition of cAMP with no discernible dif ference in the time course and concentration depen dence of RA treatment. We monitored expression of the SSEA-1 and MHC class I antigens in these cells by cytofluorography analysis using specific monoclonal anti bodies. As seen in Table 2 , binding of anti-SSEA-1 anti body was reduced to a background level after 4 days of incubation with RA both in the control and in the antisense clone 3A9. Concomitantly, MHC class I antigens became detectable both in the control and clone 3A9, with no measurable quantitative differences. These re sults show that expression of c-/os antisense RNA does not prevent the cells from differentiating following RA treatment. The absence of noticeable effects on differen tiation in the antisense clones prompted us to reex amine the expression of c-fos mRNA that is reported to occur gradually after RA treatment (MuUer 1983). We did not detect a measurable increase in c-/os mRNA levels even in untransformed F9 EC cells throughout 48 hr of RA treatment, during which levels of c-/os mRNA were tested at 0.5, 4, 6, 24, and 48 hr after treatment with 10"^ M of RA (data not shown). A similar lack of a large increase in c-fos mRNA levels during differentia tion of F9 cells has been reported (Mason et al. 1985) . Taken together, these results indicate that c-fos gene ex pression is not required for differentiation of F9 cells.
Discussion
We have shown that constitutive expression of c-fos an tisense RNA leads to a striking reduction in the basal and induced (by IFN, TPA) levels of the endogenous c-fos gene expression in F9 EC cells. The amount of c-fos mRNA and protein was decreased to a virtually unde tectable level in clones 3A9 and 2A36. The inability of these clones to induce c-/os was not due to the disrup tion of the gene, which might have occurred by a mecha nism such as homologous recombination upon intro duction of the exogenous DNA, because the endogenous C-/OS mRNA could be induced by CHX treatment (Fig.  5) . The observed induction of c-/os by CHX treatment also excludes the possiblity that a mechanism (tran scriptional or post-transcriptional) required for pro ducing C-/OS messages is permanently damaged in these clones. In addition, the blockade of c-fos expression was not due to competition for trans-acting proteins that bind to the c-fos regulatory sequence (Gilman et al. 1986; Prywes and Roeder 1986; Treisman 1986 ), which may have occurred following introduction of a large number of the 5' upstream sequence of the c-/os gene. This is evident because clones transfected with the con trol sense plasmid (pSFOS-2), containing the same 5'-flanking region in a high copy number, allowed expres sion of the endogenous c-/os gene at a level comparable to control F9 cells. Thus, it is most likely that the ob served blockade of c-/os expression is the direct conse quence of the expression of c-/os antisense RNA.
Despite the profound inhibition of c-/os gene expres sion, clones expressing c-/os antisense RNA maintained characteristics of F9 EC cells in many respects: They ex hibited morphology typical of undifferentiated F9 cells, and underwent differentiation after RA treatment. Moreover, these cells grew as rapidly as control F9 cells. Two recent studies reported that introduction of a c-/os antisense plasmid inducible by glucocorticoid interfered with the growth of NIH-3T3 cells. Nishikura and Murray (1987) reported that c-/os antisense blocked the Gi to S phase cell cycle transition in quiescent NIH-3T3 cells, although no effect was found on logarithmically growing cells. The absence of a measurable effect on the growth of F9 EC cells expressing c-/os antisense RNA noted in the present work may be due to a difference in growth properties between F9 and N1H-3T3 cells. Un like N1H-3T3 cells, F9 cells proliferate without typical contact inhibition and thus may not depend on c-fos ex pression as much. On the other hand. Holt et al. (1986) reported that colony formation of NIH-3T3 cells was in hibited strongly following induction of c-/os antisense RNA expression. In view of the observations reported herein, the results reported by these other authors are difficult to reconcile with ours. Nevertheless, it is pos sible that N1H-3T3 cells require higher levels of c-/os expression than F9 EC cells for cell growth, or that the blockade of c-fos expression was not complete in the present study and a very low level of c-fos expression was sufficient to allow cell growth. However, since Holt et al. (1986) did not examine expression of the endoge nous c-fos gene after transfection, it is possible that other unrelated changes accompanying the transfection are responsible for the described results.
How does the blockade of the endogenous c-/os gene expression occur in clones expressing c-/os antisense RNA? Since c-fos mRNA is inducible in these clones by CHX treatment, the mechanism of c-/os gene expression by IFN or phorbol ester must be different from that by CHX, which relieves the antisense-mediated blockade of c-/os gene expression. It has been proposed that superinduction of c-/os and other genes by CHX occurs by in creased transcription of the gene due to the inhibition of synthesis of a labile repressor or to stabilization of a transcriptional activator (Ringold et al. 1984; Greenberg et al. 1986) . Although this mechanism may be operative in inducing c-/os mRNA in control clones, it does not explain the relief of the blockade seen in the antisense clones, since c-/os antisense RNA is also increased by CHX treatment in these cells (Fig. 5) . As an additional and alternative mechanism of superinduction of genes by CHX, Rahmsdorf et al. (1987) indicated that CHX * F9 clones were treated with RA (10"^ M) and cAMP for 4 days. RA treated (+) and untreated (-) clones were dissociated and incubated with mouse monoclonal anti-SSEA-1 (Solter and Knowles 1978) or rat monoclonal anti-mouse MHC class I anti gens (Ozato et al. 1985) . Antibody binding was monitored by cytofluorography. Each number represents mean fluorescein value ob tained from specific antibody minus mean fluorescein value by binding of the second antibody alone.
treatment stabilizes c-fos and other mRNA, primarily by interfering with selective degradation of the messages.
As for the mechanism of the antisense action, Coleman et al. (1984) , suggested that RNA : RNA duplex formed by exogenous antisense RNA prevents binding of ribosomes which in turn could destabilize the mRNA. A similar effect of antisense RNA has been also suggested by Izant and Weintraub (1985) . Thus, the observed c-/os gene blockade by antisense RNA may be due primarily to accelerated mRNA degradation, which was arrested by CHX, leading to reexpression of the endogenous c-/os transcripts. Recently, RNA unwindase activities have been described in various cells (Rebagliati and Melton 1987; Wagner and Nishikura 1988) . It is possible that CHX treatment elevates an unwindase activity in antisense clones, which may lead to reexpression of the en dogenous C-/OS gene. Kim and Wold (1985) reported an other mechanism of antisense-mediated gene inactivation by which the antisense RNA for the thymidine kinase gene prevents transport of the mature message from the nucleus to the cytoplasm. This mechanism is less likely to play a predominant role in the system studied here because the amount of c-fos mRNA in total RNA was reduced markedly in clones expressing c-/os antisense RNA (Fig. 3) . The F9 clones that are unable to express the endoge nous c-/os gene allowed us to address the role of c-/os gene expression. We examined the widely held view that c-/os plays a role in gene regulation accompanying signal transduction, by testing whether c-/os gene expression induced by IFN is causally related to the subsequent ex pression of MHC class I genes. Our results indicate that early c-/os gene expression is not obligatory for MHC class I gene expression induced by IFN, since 3A9 and 2A36 induced normal levels of MHC class I mRNA de spite the blockade of c-/os expression. We cannot ex clude the possibility that c-/os gene expression is neces sary, and that a trace amount of c-/os mRNA present in the antisense clones was sufficient. It would be inter esting to study expression of other genes that are known to be specifically induced by IFN treatment (Friedman et al. 1984; Lamer et al. 1984) , as c-/os gene may be instru mental in expression of these genes.
Expression of c-/os gene has been also implicated in differentiation of various cells. Of particular relevance to the present study are the reports indicating that some F9 EC cells transfected with the exogenous c-/os gene un dergo morphological differentiation without RA treat ment (Muller and Wagner 1984; Ruther et al. 1985) . These observations have led these authors to propose that c-/os gene expression is at least in part responsible for differentiation of F9 cells. We found, however, that the c-/os antisense clones proceed through a normal course of differentiation following RA treatment, which is accompanied by expression of MHC class I genes and a loss of SSEA-1. These results argue that a high level of c-/os gene expression is not required for RA-induced dif ferentiation of F9 cells. Consistent with this contention, we and others (Mason et al. 1985) observed that RA treatment of F9 cells does not induce c-/os mRNA at a high level. Furthermore, Mitchell et al. (1986) reported that c-/os gene expression is not necessary for differen tiation of monocytic cells.
The most striking finding in this study is the marked reduction in the constitutive expression of c-myc mRNA in clones expressing c-/os antisense RNA. The diminished c-myc mRNA expression was seen both in 3A9 and 2A36 antisense clones but not in the 3S1 sense control clone, and was found regardless of IFN or TPA treatment. The observed downregulation was specific for c-myc, since expression of hsp70 and p53 genes was not affected, even though these two genes are, like c-myc, expressed in association with cellular growth and their activities decline after RA treatment in F9 cells (Morange et al. 1984; Dony et al. 1985; Kaczmarek et al. 1986 ). The reduced c-myc expression was not due to the disruption of the endogenous c-myc gene, because c-myc mRNA expression was rescued by CHX treatment. These results support the previously proposed notion that expression of c-/os and c-myc genes is coupled intemally (Greenberg and Ziff 1984) Regulation of c-myc gene is complex and occurs at mul tiple levels: Its transcription is controlled by multiple promoters (Broome et al. 1987) with the added com plexity of an intragenic pause and of transcription in the antisense direction (Nepveu and Marcu 1986) . Posttranscriptional regulation, i.e., selective mRNA degradation, has been also suggested (Mechti et al. 1986 ). The expres sion of c-/os gene could directly or indirectly affect c-myc mRNA accumulation through any of the above mechanism(s).
Considering the documented association between c-myc expression and cellular proliferation (Kaczmarek et al. 1986; Persson et al. 1984) , it may be surprising that the downregulation of c-myc mRNA expression did not affect overall cell growth of clones 3A9 and 2A36. How ever, expression of c-myc gene is not always linked with proliferation: Pfeifer Ohlsson et al. (1985) reported that high levels of c-myc gene expression are seen in human fetal tissues in which there is no cell division. Similarly, we observed high levels of c-myc mRNA expression in the postmitotic brain (Kasik et al. 1987) . Furthermore, Kelekar and Cole (1987) observed the absence of a mea surable level of c-myc gene expression in cells that are proliferating rapidly. These results suggest that, at least in certain cell types, c-myc gene expression is not asso ciated causally with cellular proliferation.
We have shown that introduction of a c-fos antisense plasmid into F9 EC cells effectively blocks expression of the endogenous c-/os gene, which results in profound downregulation of c-myc gene expression. The cells ex pressing c-/os antisense RNA may serve as a useful model to study further the role of c-/os.
Materials and methods
Plasmid construction
The plasmid pc-/os (mouse)-3 containing the mouse genomic c-/os gene described by was obtained through the American Type Culture Collection and was di gested with Hii2cII. A 410-bp fragment containing most of the first exon, cap site, and TATA box of c-/os gene was subcloned into the Hindi site of M13mpl9 in both orientations. HindlllXbal fragments from these two constructs were cloned into the Hindlll-Xbal sites of the mammalian expression vector pRSV2. This vector, containing the Rous sarcoma virus (RSV) pro moter, was derived from pRSV globin (Gorman et al. 1983 ) by replacing the globin sequence with polylinkers, allowing ex pression of an inserted gene in mammalian cells. The plasmid containing the c-/os fragment in the antisense orientation was designated pAFOS-2, and that in the sense orientation pSOSfos-2 (Fig. 1) .
Cell culture and DNA tiansfection
Undifferentiated F9 Tk" embryonal carcinoma cells (F9 EC cells; Gmur et al. 1980) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) and other ingredients (Wan et al. 1988 ) at 37°C in an atmo sphere of air plus 7% COg. Twenty hours before transfection, cells were seeded in 100-mm petri plates at 6 x 10^ cells per plate and then transfected with 10 fjig of pAFOS-2 or pSFOS-2 in combination with 1 | jLg of pSV2-neo (Southem and Berg 1982) using the calcium phosphate precipitation method with BES (N,N-fc>is2-hydroxyethyl-2-aminoethanesulfonic acid) buffer (pH 6.96) described by Ishiura et al. (1982) . Cells were cultured in standard medium for 48 hr, and then replated at a dilution of 1 : 10 followed by selection with G418 (Geneticin, Gibco BRL) at a final concentration of 500 |xg/ml. G418-resistant colonies were isolated 10-12 days later. Interferon (IFN)-a/p purchased from Lee Biomolecular, was used at a concentration of 1000 U/ml, which induces maximum amounts of c-/os mRNA (Wan et al. 1988 ). To induce c-/os gene expression by phorbol ester, cells were preincubated in medium containing 0.5% FBS for 18 hr, after which phorbol 12-myristate 13-acetate (TPA), obtained from Sigma, was added at a final concentration of 50 ng/ml. To induce morphological differentiation (Strickland and Mahdavi 1978; Strickland et al. 1980 ) retinoic acid (RA) was added to F9 EC cells at varying concentrations with or without dibutyryl cAMP (10-3 M). Cycloheximide (CHX) treatment of the cells was performed at 35 jxg/ml for 5 hr which inhibited more than 97% of protein synthesis .
RNA dot hybridization
To screen for clones expressing c-/os antisense RNA, total RNA was prepared from individual transfectants according to the guanidinium thiocyanate method (Chirgwin et al. 1979) . RNA (10 |xg) was dissolved in 200 [il of phosphate buffer (pH 6.8), and spotted onto nitrocellulose filters (Hybond-N, Amersham) placed in a manifold device (Schleicher and Schuell). After drying and UV irradiation, filters were hybridized with a ^^P-labeled single-stranded DNA probe prepared by primer extension from an M13 mpl9 clone containing the Hindi fragment of the c-/os gene in the reverse orientation. Preparation of singlestranded DNA probes with an M13 clone by primer extension has been described in detail (Ozato et al. 1985) . Hybridization was carried out with 5 x 10^ to 5 x 10^ cpm of radioactivity for 18 hr at 42°. The filters were washed twice with 2 x SSC at room temperature, twice with 1 x SSC plus 1% SDS at 65°C for 30 min, followed by two washes with 0.1 x SSC plus 0.1% SDS for 30 min at room temperature.
Southern hybridization
Cellular DNA was prepared according to Davis et al. (1986) . Twenty micrograms of DNA digested with HiizdIII and BamHl was electrophoresed through 0.9% agarose gel, and DNA was electroblotted onto Nytran paper (Schleicher & Schuell) ac cording to the manufacturer's instructions. The blots were hy bridized with a single-stranded DNA probe derived from an M13 mpl9 clone containing the Hindi fragment in the correct orientation under the same conditions described above.
Northern hybridization
Total RNA (20 fxg) was electrophoresed through 1% agarose gel containing 15% formaldehyde and transferred onto Nytran paper. The procedures for hybridization and the subsequent washes were the same as those described above. To detect c-/os mRNA transcribed from the endogenous c-/os gene, a singlestranded DNA probe corresponding to the fourth exon of the c-/os was used (Kasik et al. 1987; Kaufmann et al. 1987) . Singlestranded DNA probes for the first exon of mouse c-myc and major histocompatibility complex class I gene have been de scribed (Kaufmann et al. 1987; Ozato et al. 1985) . Plasmid pH 2.3 containing the human heat shock 70 gene [hspJO] (Wu et al. 1985) was donated by R. Morimoto. A BamHl-Hindlll frag ment containing the entire hsp70 gene was isolated. Plasmid p53-l 76 containing the mouse p53 gene (Zakut-Hauri et al. 1983 ) was donated by M. Oren, through S. Segal. Probes for these genes and for the second exon of the c-myc gene (a 416-bp Pstl fragment) were prepared by the method of mixed oligomer labeling (Feinberg and Vogelstein 1983) . DNA fragment (20-100 ng) was mixed with 1.25 JJLI of the mixed hexamer (0.1 U/ml, Pharmacia) and boiled in water. The samples were al lowed to cool on ice, and the Klenow fragment of DNA poly merase I (BRL) was added in the presence of 20 mM dATP, dCTP, dTTP, and ^^p-labeled dCTP in 0.2 M HEPES buffer (pH 6.5), 5 mM MgCli, 10 mM p-mercaptoethanol, and 50 mM Tris (pH 8). After 16 hr of incubation at room temperature, reactions were stopped by adding 200 | JL1 of distilled water. The labeled fragments were purified through Sephadex G-50. The steadystate amounts of c-/os, c-myc mRNA, and c-/os antisense RNA were estimated quantitatively by Bio-Rad Video Densitometer Model 620.
Detection of the c-fos protein by immunofluorescent staining
The staining procedure described by Curran et al. (1984) was used with minor modification. Glass slides coated with Cell Tak (Biopolymer, Inc.) were divided into four chambers, into which 10^ cells were seeded and incubated overnight. Cells were stimulated with TPA for 2 hr as described above. Cells were fixed with 2% paraformaldehyde in PBS for 2.5 min at room temperature. Fixation was terminated by washes with 10 mM glycine in PBS. Cells were then permeabilized by treatment with 1% NP-40 in PBS containing 10 mM glycine for 3 min, and were washed extensively. These cells were preincubated with 2% normal goat serum for 1 hr followed by incubation with 1 : 20 dilution of affinity purified rabbit antibody against the M peptide of mouse c-/os , kindly provided by T. Curran. Following four washes with PBS, cells were further incubated with 1 : 300 dilution of biotinylated goat anti-rabbit IgG (Vector) followed by incubation with fluorescein-conju-gated avidin (Vector) for 20 min. Rabbit IgG directed to sheep IgG (Cooper-Cappel) was used as a negative control. The pres ence of the cells in the field and fluorescent staining of these cells were monitored in a AXIOPHOT (Zeiss) fluorescent mi croscope under dark-phase contrast or under fluorescence exci tation at 495 nm. As a positive control for nuclear staining, qui escent, serum-starved NIH-3T3 cells were stimulated with FBS Nishikura and Murray 1987) and were stained with the same antibody under the same procedures.
Cytofluorography
Quantitative expression of major histocompatibility (MHC) class I antigens and stage-specific embryonic antigen-1 (SSEA-1) was detected by cytofluorography analysis as described (Ozato et al. 1985) . Briefly, dissociated cells were incubated with rat monoclonal antibody against MHC class I antigens (42.3.9.8 and K44) (Ozato et al. 1985) or mouse monoclonal antibody spe cific for the SSEA-1 (Solter and Knowles 1978) donated by D. Solter. Cells were incubated further with fluorescein-conjugated second antibodies of appropriate specificity. Antibody binding was monitored in the Ortho Cytofluorograph System. Mean fluorescein values were obtained on a linear scale.
